Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan
Kenro Hirata, Yasuo Hamamoto, Hirokazu Shoji, Hiroki Hara et autres
jp (code pays fourni par la source)